Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind parallel-group trial of DTacP vaccine in 2- and 3‑month-old infants
CTR20243444Phase 3Active
- Sponsor
- Hualan Biological Vaccine
- Start
- Sep 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria + tetanus + acellular pertussis vaccine, adsorbed in pertussis, diphtheria, Tetanus, sponsored by Hualan Biological Vaccine. Started Sep 2024; status: active.
02
Drugs
diphtheria + tetanus + acellular pertussis vaccine, adsorbed
03
Conditions
pertussisdiphtheriaTetanus
Beyond the preview
Go deeper on CTR20243444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243444.